GANYMED PHARMACEUTICALS AG;TRON - TRANSLATIONALE ONKOLOGIE AN DER UNIVERSITÄTSMEDIZIN DER JOHANNES GUTENBERG-UNIVERSITÄT MAINZ GEMEINNÜTZIGE GMBH
发明人:
ÖZLEM TÜRECI,UGUR SAHIN,RITA MITNACHT-KRAUS,STEFAN DENIS JACOBS,MAGDALENA JADWIGA UTSCH,CORNELIA ADRIANA MARIA HEINZ,CHRISTIANE REGINA STADLER
申请号：
PT13724523
公开号：
PT2852408T
申请日:
2013.05.21
申请国别(地区):
PT
年份:
2017
代理人:
摘要：
The present invention provides a combination therapy for effectively treating and/or preventing diseases associated with cells expressing CLDN18.2, including cancer diseases such as gastric cancer, esophageal cancer, pancreatic cancer, lung cancer, ovarian cancer, colon cancer, hepatic cancer, head-neck cancer, and cancer of the gallbladder and metastases thereof.
